FDA Approves New Sunscreen Ingredient (Bemotrizinol) Used in EU/Asia for Years
6 hours ago
- #Sunscreen Innovation
- #Skin Protection
- #FDA Approval
- FDA approves new sunscreen ingredient bemotrizinol (PARSOL Shield), the first in over 20 years.
- Bemotrizinol offers superior broad-spectrum UVA and UVB protection, is photostable, and minimally absorbed.
- Products with PARSOL Shield expected in the U.S. by end of 2026, improving competition and consumer access.
- Approval under CARES Act streamlines process, aligning with MAHA strategy to modernize sunscreen market.
- Experts highlight advantages: stronger UVA protection, better stability, and cosmetically elegant formulations.
- Recommendations for sunscreen use include broad-spectrum SPF 30+, reapplication every 2 hours, and full-body coverage.